Posts

Error in Conclusions

In the Original Investigation titled “Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial,” published online March 16, 2026, there was an error in the Conclusions section. The first sentence should have read, “In this trial, pregnant adults with OUD who were randomized to receive extended-release buprenorphine had higher rates of illicit opioid abstinence during pregnancy than those randomized to receive sublingual buprenorphine.” This article has been corrected. from JAMA Internal Medicine Online First https://ift.tt/76MOoGY
Post a Comment
Read more

Monitoring Blood Pressure Outside of Your Doctor’s Office

This JAMA Internal Medicine Patient Page discusses the differences between home blood pressure monitoring and ambulatory blood pressure monitoring and why both are an important part of maintaining good health. from JAMA Internal Medicine Online First https://ift.tt/4tNohaY
Post a Comment
Read more

Funding Nurse Recruitment While Defunding Nurse Educators

This Viewpoint discusses US federal budget decisions to eliminate funding for nursing education while recruitment programs continue, leading to an emphasis on addressing immediate needs rather than long-term workforce sustainability. from JAMA Health Forum New Online https://ift.tt/hOARWQi
Post a Comment
Read more

Utah’s Experiment With AI-Driven Prescription Renewals

This JAMA Forum discusses the design of an artificial intelligence (AI) prescription pilot program being deployed in Utah, methods for assessing system performance, and the future of the program. from JAMA Health Forum New Online https://ift.tt/gRCfTNq
Post a Comment
Read more

Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy

This randomized clinical trial of US adults treated with stable doses of glucagon-like peptide-1 and/or glucose-dependent insulinotropic polypeptide agonists examines the effects on residual gastric volume. from JAMA Internal Medicine Online First https://ift.tt/8mAlRJW
Post a Comment
Read more

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum

This randomized clinical trial evaluates whether weekly extended-release buprenorphine has noninferior effectiveness and safety outcomes compared with sublingual buprenorphine among pregnant adults with opioid use disorder. from JAMA Internal Medicine Online First https://ift.tt/K2sTMrQ
Post a Comment
Read more

JAMA Internal Medicine Peer Reviewers in 2025

We sincerely thank the 1127 peer reviewers who completed manuscript reviews for JAMA Internal Medicine in 2025. from JAMA Internal Medicine Online First https://ift.tt/9Hfe5V1
Post a Comment
Read more

eConsult-Integrated Care to Improve Specialty Access

This Viewpoint discusses eConsult-integrated care to improve access to specialty health care. from JAMA Internal Medicine Online First https://ift.tt/7ClBZHL
Post a Comment
Read more

Annual Wellness Visit Use and Risk Scores Across Medicare Advantage Insurers

This cross-sectional study assesses the use of Medicare’s Annual Wellness Visits among older patients with Medicare Advantage and traditional Medicare coverage. from JAMA Health Forum New Online https://ift.tt/KZCHf5O
Post a Comment
Read more

Instability of Global Burden of Disease Estimates of Deaths and DALYs

This meta-epidemiological assessment evaluates the reliability of the Global Burden of Disease risk factor estimates for mortality and disability-adjusted life-years. from JAMA Health Forum New Online https://ift.tt/Aip9r2O
Post a Comment
Read more

Patterns of Federal Lobbying by the Hospital Industry

This cross-sectional study quantifies federal lobbying expenditures by the hospital industry in 2024 and compares variations in lobbying expenditures by hospital ownership status. from JAMA Health Forum New Online https://ift.tt/iBlTKuH
Post a Comment
Read more

Modeling the Make America Healthy Again's Food Policy Strategy on Tobacco

This Viewpoint discusses the Make America Healthy Again Commission’s “Make Our Children Healthy Again” report, which implicates the food industry for its role in the chronic disease epidemic. from JAMA Health Forum New Online https://ift.tt/HWtRPKT
Post a Comment
Read more